ETFsMSCI ACWI EMERGING MARKET CONSUMER GROWTH Index Net
iShares
iShares MSCI EM Consumer Growth UCITS ETF
CEMG XETRAAccumulatingPhysical, full replicationIreland
Last close · EUR
31.04EUR
+0.52% · +€0.16
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
CEMGBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- -7.9%Index +11.4%
- Sharpe 3Y
- 0.09Index 0.93
- Volatility 1Y
- 12.4%annualised
- Holdings
- 265Fund holdings
Performance
Compare
- CEMG-7.9%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| CEMG | +5.1% | -1.4% | +3.3% | -3.7% | -7.9% | +14.5% | -9.8% |
| MSCI Emerging Markets IMI | -13.6% | -7.4% | -5.4% | +13.0% | +11.4% | +56.7% | +38.4% |
| Gap to MSCI Emerging Markets IMI | +18.6% | +6.0% | +8.7% | -16.7% | -19.4% | -42.2% | -48.2% |
Risk and return
Sharpe ratio · 3Y
0.09
Below MSCI Emerging Markets IMI · 0.93- Return p.a.
- +3.1%
- Volatility
- 15.3%
- Max loss
- -20.2%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
CEMG
0.09
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 29.5%
- Holdings
- 265
- As of
- 1ALIBABA GROUP HOLDING3.90%
- 2UNILEVER PLC3.86%
- 3NETFLIX3.85%
- 4MERCADOLIBRE3.04%
- 5BHARTI AIRTEL LTD2.91%
- 6TOYOTA MOTOR2.60%
- 7MEITUAN2.39%
- 8XIAOMI2.33%
- 9PDD HOLDINGS ADS2.31%
- 10ANHEUSER-BUSCH INBEV SA2.28%
Countries
Classified 87.7%
China29.6%
India16.1%
Unknown12.3%
Other11.5%
JP
GB
MX
CH
TW
ZA
BE
SG
NL
SE
- Largest
- 29.6%China
- Top 3
- 51.7%
- Effective number
- 8.01 / HHI
Market cap
Weight vs holdings
29.5%of the fund sits in the top 10 holdings
29.5%36.0%31.8%
WeightHoldings
4015065
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
